Background Randomized trials have shown that complete revascularization in patients with ST-segment elevation myocardial infarction (MI) with multivessel disease results in lower major adverse cardiovascular events (MACE) (all-cause death, MI, ischemia-driven revascularization, heart failure). Objectives The goal of this study was to determine whether the benefits of complete revascularization…
IRIS Team, CarMeN Lab, INSERM U1060, INRAE, Claude Bern ard Lyon 1 University, Bron, France Edouard Herriot Hospital, Hospices Civils of Lyon, Lyon, France IRIS…
AbstractBackgroundThe growing use of leadless pacemaker (LP) technology requires safe and effective solutions for retrieving and removing these devices over the long term.ObjectivesThis study sough…
AbstractBackgroundIn the STOP-CA (Statins to Prevent the Cardiotoxicity From Anthracyclines) trial, atorvastatin preserved the left ventricular ejection fraction among patients with lymphoma treate…
AbstractBackgroundContact force (CF) changes after onset of radiofrequency (RF) delivery are not well understood and often ascribed to catheter instability.ObjectivesThis study sought to characteri…
Internal Medicine Department, Boston Medical Center, Boston University School of Medicine, Massachusetts Internal Medicine Department, Boston Medical Center, Boston University School of Medicine, Massachusetts Cardiovascular…
Gurusher S. Panjrath, MBBS, FACC Barbara Wiggins, PharmD, FACC Megan Coylewright, MD, MPH, FACC – Ex Officio 2. Assumptions and Definitions 3 2.1. General Clinical…
AbstractBackgroundIn severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM), the VALOR-HCM (A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrop…
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions…
Coming Soon: ACC.25 Featured Research from JACC Journals Get ready for simultaneous publications from JACC, JACC: Case Reports, JACC: Heart Failure, JACC: CardioOncology, JACC: Advances,…
Pre-Conference Programs at ACC.25 offer you an opportunity to extend your learning experience by arriving a day early. Get hands-on experience with renal denervation technology…
